We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OHAI
3076
DELISTED
OHA Investment Corporation
OHAI
$117K ﹤0.01%
92,334
-23,168
-20% -$33.3K
SBSW icon
3077
Sibanye-Stillwater
SBSW
$7.02B
$115K ﹤0.01%
26,312
+11,382
+76% +$75.5K
MOBL
3078
DELISTED
MobileIron, Inc.
MOBL
$113K ﹤0.01%
18,690
-20,882
-53% -$109K
SSRI
3079
DELISTED
Silver Standard Resources
SSRI
$110K ﹤0.01%
+11,366
New +$114K
ACTG icon
3080
Acacia Research
ACTG
$439M
$109K ﹤0.01%
26,640
-2,000
-7% -$9.31K
ERII icon
3081
Energy Recovery
ERII
$457M
$109K ﹤0.01%
13,091
+2,620
+25% +$21K
HERZ
3082
Herzfeld Credit Income Fund
HERZ
$31.7M
$108K ﹤0.01%
1,939
-1,457
-43% -$79.9K
GSAT icon
3083
Globalstar
GSAT
$10.7B
$108K ﹤0.01%
3,367
CXH
3084
DELISTED
MFS Investment Grade Municipal Trust
CXH
$106K ﹤0.01%
+10,489
New +$105K
WVVI icon
3085
Willamette Valley Vineyards
WVVI
$12.7M
$106K ﹤0.01%
13,075
NPKI
3086
NPK International
NPKI
$1.15B
$105K ﹤0.01%
14,259
-21,274
-60% -$162K
KERX
3087
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$105K ﹤0.01%
14,491
-10,410
-42% -$65K
DMF
3088
DELISTED
BNY Mellon Municipal Income
DMF
$104K ﹤0.01%
11,596
EVEP
3089
DELISTED
EV Energy Partners, L.P.
EVEP
$104K ﹤0.01%
165,039
-32,185
-16% -$36.5K
MGF
3090
Aberdeen Government Markets Income Fund
MGF
$92.2M
$103K ﹤0.01%
20,479
+40
+0.2% +$198
OMER icon
3091
CALL
Omeros
OMER
$916M
$103K ﹤0.01%
45,300
+31,400
+226% +$548K
BBG
3092
DELISTED
Bill Barrett Corp
BBG
$103K ﹤0.01%
+33,693
New +$125K
FGB
3093
DELISTED
First Trust Specialty Finance and Financial Opportunities Fund
FGB
$102K ﹤0.01%
14,108
+1,500
+12% +$11.1K
GE icon
3094
CALL
GE Aerospace
GE
$396B
$101K ﹤0.01%
61,681
-10,412
-14% -$1.43M
CLNE icon
3095
Clean Energy Fuels
CLNE
$414M
$98K ﹤0.01%
38,543
+3,200
+9% +$7.93K
EOD
3096
Allspring Global Dividend Opportunity Fund
EOD
$283M
$98K ﹤0.01%
15,979
-18,246
-53% -$112K
MCN
3097
Madison Covered Call & Equity Strategy Fund
MCN
$118M
$97K ﹤0.01%
12,433
-1,600
-11% -$12.7K
TLPH icon
3098
Talphera
TLPH
$70.1M
$97K ﹤0.01%
2,250
EAD
3099
Allspring Income Opportunities Fund
EAD
$378M
$96K ﹤0.01%
11,189
-100
-0.9% -$857
MAR icon
3100
CALL
Marriott International
MAR
$94.2B
$94K ﹤0.01%
10,700
-11,700
-52% -$1.17M

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.